
Single-cell sequencing refers to the amplification and sequencing of transcriptomes or genomes at the level of individual cells to detect single cells in the genome (Structural Variations-SVs; Copy number variants-CNVs; Single Nucleotide Variants-Single nucleotide variants-SNVs, etc.), transcriptomics (RNA expression level; alternative splicing of transcripts), epiomics (DNA methylation, etc.), proteomics and multiple omics data...
The global Single Cell Sequencing Platform market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Single Cell Sequencing Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Single Cell Sequencing Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Single Cell Sequencing Platform in Neurobiology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Single Cell Sequencing Platform include 10x Genomics, BD, Fluidigm Corporation, Illumina/Bio-Rad, Takara Bio, 1CellBio and MissionBio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Single Cell Sequencing Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Cell Sequencing Platform.
Report Scope
The Single Cell Sequencing Platform market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Single Cell Sequencing Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single Cell Sequencing Platform companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
10x Genomics
BD
Fluidigm Corporation
Illumina/Bio-Rad
Takara Bio
1CellBio
MissionBio
Segment by Type
Microfluidic Separation
Microdroplet Separation
Microporous Separation
Combined Labeling
Other
Segment by Application
Neurobiology
Immunology
Cancer Medicine
Plant Biology
Forensics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single Cell Sequencing Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single Cell Sequencing Platform Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Microfluidic Separation
1.2.3 Microdroplet Separation
1.2.4 Microporous Separation
1.2.5 Combined Labeling
1.2.6 Other
1.3 Market by Application
1.3.1 Global Single Cell Sequencing Platform Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Neurobiology
1.3.3 Immunology
1.3.4 Cancer Medicine
1.3.5 Plant Biology
1.3.6 Forensics
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single Cell Sequencing Platform Market Perspective (2019-2030)
2.2 Single Cell Sequencing Platform Growth Trends by Region
2.2.1 Global Single Cell Sequencing Platform Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Single Cell Sequencing Platform Historic Market Size by Region (2019-2024)
2.2.3 Single Cell Sequencing Platform Forecasted Market Size by Region (2025-2030)
2.3 Single Cell Sequencing Platform Market Dynamics
2.3.1 Single Cell Sequencing Platform Industry Trends
2.3.2 Single Cell Sequencing Platform Market Drivers
2.3.3 Single Cell Sequencing Platform Market Challenges
2.3.4 Single Cell Sequencing Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single Cell Sequencing Platform Players by Revenue
3.1.1 Global Top Single Cell Sequencing Platform Players by Revenue (2019-2024)
3.1.2 Global Single Cell Sequencing Platform Revenue Market Share by Players (2019-2024)
3.2 Global Single Cell Sequencing Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Single Cell Sequencing Platform Revenue
3.4 Global Single Cell Sequencing Platform Market Concentration Ratio
3.4.1 Global Single Cell Sequencing Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single Cell Sequencing Platform Revenue in 2023
3.5 Single Cell Sequencing Platform Key Players Head office and Area Served
3.6 Key Players Single Cell Sequencing Platform Product Solution and Service
3.7 Date of Enter into Single Cell Sequencing Platform Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Single Cell Sequencing Platform Breakdown Data by Type
4.1 Global Single Cell Sequencing Platform Historic Market Size by Type (2019-2024)
4.2 Global Single Cell Sequencing Platform Forecasted Market Size by Type (2025-2030)
5 Single Cell Sequencing Platform Breakdown Data by Application
5.1 Global Single Cell Sequencing Platform Historic Market Size by Application (2019-2024)
5.2 Global Single Cell Sequencing Platform Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Single Cell Sequencing Platform Market Size (2019-2030)
6.2 North America Single Cell Sequencing Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Single Cell Sequencing Platform Market Size by Country (2019-2024)
6.4 North America Single Cell Sequencing Platform Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single Cell Sequencing Platform Market Size (2019-2030)
7.2 Europe Single Cell Sequencing Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Single Cell Sequencing Platform Market Size by Country (2019-2024)
7.4 Europe Single Cell Sequencing Platform Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Single Cell Sequencing Platform Market Size (2019-2030)
8.2 Asia-Pacific Single Cell Sequencing Platform Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Single Cell Sequencing Platform Market Size by Region (2019-2024)
8.4 Asia-Pacific Single Cell Sequencing Platform Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Single Cell Sequencing Platform Market Size (2019-2030)
9.2 Latin America Single Cell Sequencing Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Single Cell Sequencing Platform Market Size by Country (2019-2024)
9.4 Latin America Single Cell Sequencing Platform Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single Cell Sequencing Platform Market Size (2019-2030)
10.2 Middle East & Africa Single Cell Sequencing Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Single Cell Sequencing Platform Market Size by Country (2019-2024)
10.4 Middle East & Africa Single Cell Sequencing Platform Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 10x Genomics
11.1.1 10x Genomics Company Detail
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics Single Cell Sequencing Platform Introduction
11.1.4 10x Genomics Revenue in Single Cell Sequencing Platform Business (2019-2024)
11.1.5 10x Genomics Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD Single Cell Sequencing Platform Introduction
11.2.4 BD Revenue in Single Cell Sequencing Platform Business (2019-2024)
11.2.5 BD Recent Development
11.3 Fluidigm Corporation
11.3.1 Fluidigm Corporation Company Detail
11.3.2 Fluidigm Corporation Business Overview
11.3.3 Fluidigm Corporation Single Cell Sequencing Platform Introduction
11.3.4 Fluidigm Corporation Revenue in Single Cell Sequencing Platform Business (2019-2024)
11.3.5 Fluidigm Corporation Recent Development
11.4 Illumina/Bio-Rad
11.4.1 Illumina/Bio-Rad Company Detail
11.4.2 Illumina/Bio-Rad Business Overview
11.4.3 Illumina/Bio-Rad Single Cell Sequencing Platform Introduction
11.4.4 Illumina/Bio-Rad Revenue in Single Cell Sequencing Platform Business (2019-2024)
11.4.5 Illumina/Bio-Rad Recent Development
11.5 Takara Bio
11.5.1 Takara Bio Company Detail
11.5.2 Takara Bio Business Overview
11.5.3 Takara Bio Single Cell Sequencing Platform Introduction
11.5.4 Takara Bio Revenue in Single Cell Sequencing Platform Business (2019-2024)
11.5.5 Takara Bio Recent Development
11.6 1CellBio
11.6.1 1CellBio Company Detail
11.6.2 1CellBio Business Overview
11.6.3 1CellBio Single Cell Sequencing Platform Introduction
11.6.4 1CellBio Revenue in Single Cell Sequencing Platform Business (2019-2024)
11.6.5 1CellBio Recent Development
11.7 MissionBio
11.7.1 MissionBio Company Detail
11.7.2 MissionBio Business Overview
11.7.3 MissionBio Single Cell Sequencing Platform Introduction
11.7.4 MissionBio Revenue in Single Cell Sequencing Platform Business (2019-2024)
11.7.5 MissionBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
10x Genomics
BD
Fluidigm Corporation
Illumina/Bio-Rad
Takara Bio
1CellBio
MissionBio
Ìý
Ìý
*If Applicable.
